Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.9287
+0.0756 (8.86%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9300
+0.0013 (0.14%)
After-hours: Oct 8, 2025, 7:24 PM EDT
Adicet Bio Employees
Adicet Bio had 152 employees as of December 31, 2024. The number of employees increased by 9 or 6.29% compared to the previous year.
Employees
152
Change (1Y)
9
Growth (1Y)
6.29%
Revenue / Employee
n/a
Profits / Employee
-$780,500
Market Cap
77.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 152 | 9 | 6.29% |
Dec 31, 2023 | 143 | 11 | 8.33% |
Dec 31, 2022 | 132 | 46 | 53.49% |
Dec 31, 2021 | 86 | 4 | 4.88% |
Dec 31, 2020 | 82 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACET News
- 1 day ago - Adicet Bio, Inc. - Special Call - Seeking Alpha
- 1 day ago - Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 - Benzinga
- 1 day ago - Adicet Bio, Inc. Announces $80 Million Registered Direct Offering - Business Wire
- 1 day ago - Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) - Business Wire
- 8 days ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 5 weeks ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates - Business Wire